Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
we will see.
GOFH - GoFish Corporation, a Leading User-Generated Video Company, Goes Public and Completes $12 Million Financing
SAN FRANCISCO, Oct 31, 2006 (Canada NewsWire via COMTEX) -- GoFish Corporation (OTCBB:GOFH), Formerly Unibio, Inc., today announced the closing of a stock-for-stock merger with GoFish Technologies, Inc. The combined company will operate under the name GoFish Corporation and will assume and execute GoFish Technologies' user-generated video business plan as its sole business. GoFish will retain senior management led by its founder and CEO Michael Downing.
In contemplation of the merger, GoFish completed a $12 million private placement of common stock and warrants to a group of institutional and private investors. The company plans to use the funds to strengthen its corporate infrastructure and product offerings, which will enable GoFish to deliver the next-generation consumer online video experience. "The successful completion of the merger and financing represent a major milestone for GoFish, positioning the company for accelerated growth," said Downing. "The financial resources and corporate visibility provided by today's announcement will enable us to accelerate the development of our online products, recruit additional key team members and build out our infrastructure as well as aggressively grow our community of video enthusiasts."
GoFish Corporation is a leading online video destination for user-generated video, as well as commercial video content, accessible on-demand. Members of the GoFish community have watched hundreds of millions of videos over the last two years utilizing the GoFish platform to upload, share, search for and watch videos from around the world. GoFish was one of the earliest companies to deliver innovative technology in the user-generated video space, and recently launched a first-of-its-kind branded original programming product -- a reality themed video series called "America's Dream Date."
GoFish was founded in 2003 by current CEO Michael Downing. GoFish.com is currently visited by more than 2.5 million unique users every month. GoFish's devoted user base and innovative technologies position the company well in the emerging online video advertising market. According to research by eMarketer, the market for online video advertising is expected to grow from $385 million in 2006 to $2.35 billion by 2010. 63.6% of all US Internet users in August 2006 streamed video online, equating to 110 million people, according to ComScore.
About GoFish Corporation
GoFish Corporation, headquartered in San Francisco, is a leading consumer online video destination which in two years has grown to deliver millions of videos per month to a rapidly growing audience of enthusiasts. GoFish is a place on the web where millions of people come to upload, share and watch their favorite videos. For more information about the company, go to www.gofish.com.
Forward-Looking Statements
This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements including, but not limited to, our inability to generate sufficient operating cash flow from advertising revenue, a reduction in the demand for user-generated video and related services, a fall-off in search engine directed traffic to our web site, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in the our reports filed with the Securities and Exchange Commission, including those risks set forth in the Company's Current Report on Form 8-K filed on October 31, 2006, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
SOURCE: GoFish Corporation
CONTACT: Big Mouth Communications Amy Bonetti, 415-384-0900 (Media) amy@bigmouthpr.com Susie
Marino, 415-613-9138 (Media) dearsusan@marino.com or Market Street Partners Joann
Horne, 415-445-3233 (Investors) joann@marketstreetpartners.com Nate Wright,
415-445-3239 (Investors) nate@marketstreetpartners.com
Copyright (C) 2006 CNW Group. All rights reserved.
-0-
KEYWORD: California
INDUSTRY KEYWORD: MLM
Search for Dun &
MHLXZ popped to .07 today, now .035 fwiw
CNCN news, buys going off above ask..fwiw
A few of interest
PPBL, MMGP,RLTR
CMKI first Gov. contract
EVSP ?(R/M news)
MGWB (volume)
SYEV filing due and move to the OTC.
still watching HMGP now .022
IDVJ contract news .008
JMO
Actually the main prob has been the kick backs...lol
My monthly thank you for doing a great job on this board Pat.
on watch... HEGP...
HEGP Reduces Issued and Outstanding Shares By 42 Million
Friday October 27, 2:54 pm ET
ALEXANDRIA, La.--(BUSINESS WIRE)--Heartland Energy Group Inc. (Pink Sheets:HEGP - News) announced today that it has retired 42,455,000 shares.
The company has now completed the divesture of Plantworld International, Inc and as such, the shares that were issued in the transaction have now been cancelled. Roy Thornhill stated: "The board has decided to immediately reduce Heartland Energy's issued and outstanding shares by 42,455,000 shares. We have done this to preserve and increase our shareholder value."
Ethanol Industry:
The growing interest in ethanol, a clean, corn-based renewable resource, has paralleled the escalating price of gas and the urgent need to break the country's dependence on crude oil. Recently, the Big Three automobile manufacturers, GM (NYSE:GM - News), Ford (NYSE:F - News), and DaimlerChrysler (NYSE:DCX - News), appealed to Congress for incentives to increase the number of gas stations that offer blends of ethanol. Last year, Microsoft (NasdaqGS:MSFT) co-founder Bill Gates invested $84 million into Pacific Ethanol (NasdaqGM:PEIX). Sir Richard Branson, chairman of the Virgin Group and worth an estimated $3 Billion, has plans to invest $300 to $400 million to produce and market this alternative fuel. Vinod Khosla, "guru" of Silicon Valley, co-founder of Sun Microsystems (NasdaqGS:SUNW), and one of ethanol's most vocal advocates, has personally invested millions in private companies involved in the development of ethanol.
About Heartland Energy Group, Inc.:
Heartland Energy Group, Inc. is a North American-based alternative fuel resource and service company, dedicated to developing the infrastructure for the delivery of ethanol (e85). Heartland seeks to eliminate North America's dependency on foreign energy sources by focusing on innovative engineering that will enable the mass distribution of ethanol. Heartland Energy Group will transcend the future of renewable energy resources, with the ultimate goal of creating a cleaner brighter energy solution for North America. For more information, visit us at www.HeartlandEnergyGroup.com.
Forward-Looking Statements:
Based on current expectations and assumptions, forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical experience and projections. Such forward-looking statements are inherently uncertain, and actual results may differ from those expressed or implied. Consequently, readers should not place undue reliance on any forward-looking statements. Heartland Energy Group, Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contact:
Heartland Energy Group, Inc.
Roy Thornhill, 318-449-9490
www.heartlandenergygroup.com
--------------------------------------------------------------------------------
Source: Heartland Energy Group Inc.
Thnx Merci, in a dif. market where the MM's and brokers were not being so greedy I might try some.
still on watch though.
on watch...HMGP...
Hemi Energy Group, Inc. Completes Three Months of Oil Shipments from Kansas
Friday October 27, 11:53 am ET
GRAHAM, Texas--(BUSINESS WIRE)--Hemi Energy Group, Inc. (Pink Sheets: HMGP - News) has completed three months of ongoing production and shipments from its Kansas leases. Tanks are nearly at the capacity required for another pickup, and will be ready for shipment in early November from the leases located in Woodson County, Kansas. Since the acquisitions, the company and contract service crews are continuing to rehabilitate, test pump, re-work and upgrade wells, thereby increasing average daily production on a well-by-well basis.
ADVERTISEMENT
Keith A. Anderson, CEO and president of Hemi Energy Group, left on an inspection trip Thursday, Oct. 26, to do a detailed valuation of reconditioned and rebuilt equipment at the wells located on over 3 square miles of leases in eastern Kansas. A substantial amount of time and funds has been invested on this equipment, i.e., tanks, pump jacks, pumps, etc., to improve the value of the lease properties.
On this trip Mr. Anderson will also be meeting with landowners/mineral owners in Woodson County whose properties are adjacent to or near the existing leases. These meetings will be early discussions in regard to possible future expansion in this area.
About Hemi
Hemi Energy Group is an independent crude oil and natural gas producer employing a unique business model capitalizing on technological advances to exploit mature fields with millions of barrels of proven oil remaining in the ground. Using attractive lease/royalty packages, Hemi has secured, in its history, tens of thousands of acres of productive domestic projects. The company's forward-thinking strategy has placed it in an enviable position at a time when prices and global demand for oil continue to rise. Building on decades of experience in enhanced oil recovery, Hemi has successfully amassed a substantial and attractive portfolio of these high-quality domestic properties. By streamlining operations through cutting-edge technologies, Hemi has the ability to operate more effectively and efficiently than larger oil companies.
For additional information, please go to http://hemienergy.com or http://www.stockinformationsystems.com/c/HMGP/index.html.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.
Contact:
Stock Information Systems Inc.
Jim McBeth, 801-568-1873
--------------------------------------------------------------------------------
Source: Hemi Energy Group, Inc.
Hi Mizz Missy
Quan Yin, the great goddess and Mother of Compassion
Quan Yin loved and revered throughout Asia. A beautiful expression of Divine Mother. Mercy means there is more assistance given through love than through merit earned. Following her ascension Kwan Yin turned back to save others and made this pledge - "Never will I seek, nor receive, private individual salvation, never will I enter into final peace alone, but forever and everywhere will I live and strive for the redemption of every creature throughout the world from the bonds of conditioned existence". Kwan Yin is associated with the earth, fertility, and birth, and healing. She has also brought forth the energies of Magnified Healing. Quan Yin is known as the Goddess of Compassion and is often depicted riding on a dragon. She is the eastern counterpart of Mother Mary and she works to balance the feminine energy. She is one of the Lords of Karma representing the sixth ray. Isis carried the same 'mother energy' in Egyptian and Hinduism, Shakti (Vishnu's wife), Pavarti (Shiva's wife) and Sita (Rama's wife). Her proper name is Kuanshih Yin and means "She who harkens to the cries of the world". She is honored in Japan and China. A Celestial Bodhisatva and Ascended Master. Quan-Yin
Ascended Master - a being who has become Self-Realized and serves humanity;
a being who has raised his/her vibration to a sustained frequency of light.
He/she can come and go at will from the earth plane without the Birth//Death cycle.
Self-Realization - the awareness of our complete and indivisible union with God,
which we are. This also means that the ego-self has come to know itself so clearly,
so lovingly, so wisely that it is no longer run by the Shadow.
When one is in the Illumined State or Self-Realized,
there ceases to be any more inner or outer drama.
The personal ego-self has surrendered fully and willingly into the loving embrace of the Soul
No kidding any changes will be put off for a year...shaking my head
Another slant, SEC Will Be Investigated in Probe Sought by Senate's Grassley
By Otis Bilodeau
Oct. 26 (Bloomberg) -- The U.S. Securities and Exchange Commission,
already under scrutiny for its handling of a trading probe that
entangled Morgan Stanley Chief Executive Officer John Mack, now faces
a broad review by government auditors of its management and methods
for policing the financial markets.
The Government Accountability Office agreed last week to investigate
the SEC's enforcement division and compliance department after
requests by Senator Charles Grassley, an Iowa Republican who
questioned whether the agency gave Mack special treatment. Grassley
asked the GAO to examine the SEC's ``planning, oversight, control and
other management processes'' and gauge whether the agency does enough
to oversee regulators at the New York Stock Exchange and NASD.
``Based upon allegations I have received over the past few months, I
have become increasingly concerned regarding the operations of the
SEC, and whether the SEC is faithfully adhering to its mission'' to
protect investors, Grassley, the chairman of the Senate Finance
Committee, wrote in one of two Sept. 19 letters to GAO Comptroller
General David Walker.
The review ratchets up the heaviest political pressure the SEC has
faced since Christopher Cox, a California Republican, took over as
its chairman in August 2005. Grassley's requests target units run by
SEC enforcement chief Linda Thomsen and Lori Richards, head of the
Office of Compliance, Inspections and Examinations.
Senators including Grassley are concerned that the SEC shielded Mack
from a probe of insider trading at Pequot Capital Management Inc.,
which runs $7 billion in hedge funds. Gary Aguirre, a former SEC
investigator, told the Senate Judiciary Committee in June that he was
blocked from questioning Mack because of the Morgan Stanley CEO's
political clout. New York- based Morgan Stanley is one of Wall
Street's two biggest securities firms.
`Coating of Dirt'
The SEC eventually interviewed Mack in July and notified him and
Westport, Connecticut-based Pequot earlier this month that it won't
pursue a case against them. The SEC repeatedly has denied Aguirre's
claims and Mack and Pequot denied any wrongdoing.
``This Aguirre story will leave a coating of dirt unless it is probed
and washed away,'' said Edward Fleischman, a former SEC commissioner
now in private practice at Linklaters in New York. ``It will benefit
us all, and it will ultimately benefit the SEC, to have the GAO go
through all of this as an outside observer.''
Thomsen declined to comment. Walter Ricciardi, a deputy enforcement
director at the SEC, said the agency has no objection to the GAO
inquiry.
``We welcome the review and look forward to any recommendations that
might follow,'' Ricciardi said in an interview.
Donaldson Appointee
Thomsen is the only division director at the SEC not appointed by
Cox. She was promoted in May 2005 by Cox's predecessor, William
Donaldson, after then-Enforcement Director Stephen Cutler returned to
private practice.
Cox said Oct. 18 that members of Congress have ``legitimate concerns
and I share those concerns'' when asked about Aguirre's allegations.
Grassley asked the GAO, Congress's investigative arm, to report its
findings by June. The GAO said in an Oct. 16 letter to Grassley that
it ``accepts these requests as work that is within the scope of its
authority.''
The inner workings of the SEC's enforcement division are rarely
exposed to public view. As a matter of policy, the agency doesn't say
when it opens or closes investigations and officials won't discuss
their progress in building a case.
NYSE, NASD Oversight
Grassley asked the GAO to assess how the SEC tracks investigations,
the amount of time the agency takes to complete them and its
``reported success rate.'' He also requested that the auditors
determine how many referrals of potentially illegal trading activity
from U.S. exchanges ``actually become part of a regulatory action.''
SEC enforcers rely on the self-regulatory organizations, or SROs,
that police the exchanges, including NYSE Regulation and the NASD, to
report signs of suspicious trading for further investigation.
The SEC must ``detect and deter potential abuses of SRO authority
arising from inherent conflicts of interest,'' Grassley wrote to the
GAO. ``How does the SEC ensure that the SROs vigorously oversee their
own members?''
An analysis of stock-trading data by Toronto-based Measuredmarkets
Inc. showed in August there may have been insider trading in advance
of 41 percent of the largest U.S. takeover announcements in the
preceding year. Derivatives traders also made perfectly timed bets
before public announcements of recent deals such as the $33 billion
leveraged buyout of hospital operator HCA Inc.
Hedge Funds
About 20 percent of the new investigations opened at the SEC in the
past year focused on insider trading and slightly less than half of
those probes led to enforcement cases, according to Ricciardi.
``We often see suspicious trading, but in some cases it's hard to
find the evidence,'' he said in an Aug. 27 interview.
Cox said Oct. 18 that the SEC is ramping up its scrutiny of potential
insider trading by hedge funds ahead of company mergers. Thomsen, the
enforcement chief, told Congress last month that cases of insider
trading by hedge funds have become a ``significant concern.'' Hedge
funds are private pools of capital that allow managers to participate
substantially in the gains they make for investors.
Fed Keeps Key Interest Rate Unchanged
Wednesday October 25, 2:17 pm ET
By Martin Crutsinger, AP Economics Writer
Fed Keeps Key Interest Rate Unchanged for 3rd Consecutive Meeting
WASHINGTON (AP) -- The Federal Reserve kept interest rates unchanged on Wednesday for a third consecutive meeting, hoping that a slowing economy will dampen a worrisome rise in inflation.
The Fed left its federal funds rate at 5.25 percent. It has been at that level since late June when the central bank raised rates for a 17th consecutive time in a two-year effort to combat rising inflation.
The decision to keep the funds rate unchanged means that the prime lending rate, the benchmark for millions of consumer and business loans, will remain at 8.25 percent.
CVNI -- Clearvision International, Inc.
Clearvision International, Inc. Announces 2-1 Dividend
W. HOLLYWOOD, Calif., Oct 25, 2006 (BUSINESS WIRE) -- Clearvision International, Inc. (OTC.PK:CVNI) announced its directors and a majority of its shareholders approved a 2 for 1 forward stock split today. The record date will be October 27, 2006, and the payment date will be November 7, 2006. Common stock shareholders as of record date will be entitled to receive one share of common stock for each share owned as of that date, which will be paid in the form of a share dividend on November 7, 2006. Market participants are encouraged to review corporate information posted by the Company with the Pink Sheets News Service at www.pinksheets.com.
Clearvision International, Inc. is a leading media production, corporate branding and news placement organization. Clearvision serves clients large and small, public and private. The company provides traditional public relations placements and also arranges celebrity spokespersons to endorse a client's name, product or services along with ad and infomercial campaigns. Clearvision also operates Fortune Broadcasting Communications (www.fortunebroadcasting.com) a fully integrated video production company, creating Video News Releases and television commercials covering client products and business.
Disclaimer
The foregoing discussion contains forward-looking statements, which are based on current expectations. Actual results, including the timing and amount of revenues recognized, contracts awarded and performed and net income may differ due to such factors as: delays in payment on contracts due to dealings with governmental and foreign entities; fluctuations in operating costs associated with changes in project specifications; economic and other conditions affecting the ability of prospective clients to finance projects; and other risks generally affecting the financing of projects. Investors are cautioned to perform a proper due diligence and consult licensed professionals prior to making an investment decision.
SOURCE: Clearvision International, Inc.
CONTACT: Clearvision Int'l/ Fortune Broadcasting Communications
David Alvarado, Executive Producer
Main: 323-850-2988
Fax: 323-850-2989
Website: www.fortunebroadcasting.com
Copyright Business Wire 2006
-0-
KEYWORD: United States
North America
California
INDUSTRY KEYWORD: Professional Services
Finance
Communications
Advertising
Marketing
Public Relations/Investor Relations
SUBJECT CODE: Dividend
Search for Dun & Bradstreet reports on this company.
CVNI -- Clearvision International, Inc.
Com ($0.001)
COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Clearvision International, Inc. Announces 2-1 Dividend
W. HOLLYWOOD, Calif., Oct 25, 2006 (BUSINESS WIRE) -- Clearvision International, Inc. (OTC.PK:CVNI) announced its directors and a majority of its shareholders approved a 2 for 1 forward stock split today. The record date will be October 27, 2006, and the payment date will be November 7, 2006. Common stock shareholders as of record date will be entitled to receive one share of common stock for each share owned as of that date, which will be paid in the form of a share dividend on November 7, 2006. Market participants are encouraged to review corporate information posted by the Company with the Pink Sheets News Service at www.pinksheets.com.
Clearvision International, Inc. is a leading media production, corporate branding and news placement organization. Clearvision serves clients large and small, public and private. The company provides traditional public relations placements and also arranges celebrity spokespersons to endorse a client's name, product or services along with ad and infomercial campaigns. Clearvision also operates Fortune Broadcasting Communications (www.fortunebroadcasting.com) a fully integrated video production company, creating Video News Releases and television commercials covering client products and business.
Disclaimer
The foregoing discussion contains forward-looking statements, which are based on current expectations. Actual results, including the timing and amount of revenues recognized, contracts awarded and performed and net income may differ due to such factors as: delays in payment on contracts due to dealings with governmental and foreign entities; fluctuations in operating costs associated with changes in project specifications; economic and other conditions affecting the ability of prospective clients to finance projects; and other risks generally affecting the financing of projects. Investors are cautioned to perform a proper due diligence and consult licensed professionals prior to making an investment decision.
SOURCE: Clearvision International, Inc.
CONTACT: Clearvision Int'l/ Fortune Broadcasting Communications
David Alvarado, Executive Producer
Main: 323-850-2988
Fax: 323-850-2989
Website: www.fortunebroadcasting.com
Copyright Business Wire 2006
-0-
KEYWORD: United States
North America
California
INDUSTRY KEYWORD: Professional Services
Finance
Communications
Advertising
Marketing
Public Relations/Investor Relations
SUBJECT CODE: Dividend
Search for Dun & Bradstreet reports on this company.
New owners...
Officers: Chatpoom Thanomlek, President/Dir.; Daowadee Thanomlek, Dir./Secretary
http://www.pinksheets.com/quote/company_profile.jsp?symbol=MGWB
Be all that you are!
Chakra bridging enriches out connectedness to the degree
we individually and collectively purify ourselves within a full-spectrum focus.
Breathing is of two types, the correct way and the incorrect way. The correct way is abdominal breathing and the incorrect way is chest breathing. It is the diaphragm, which enables the lungs to expand and to contract. The lungs by themselves do not have the capacity to expand in order to draw in air, or to contract in order to expel used-up air. With abdominal breathing, the abdomen is slightly pushed out during inhalation, causing the diaphragm to be pulled down, which enables the lungs to draw in more air. During exhalation, the abdomen is slightly pulled in, causing the diaphragm to be pushed up, which enables the lungs to exhale more used-up air. Also, more pranic energy is drawn in during inhalation and more used-up energy is expelled during exhalation.
With chest breathing, the abdomen is pulled in during inhalation, causing the diaphragm to be pushed up resulting in less air being drawn in. During exhalation, the abdomen is pushed out, causing the diaphragm to be pulled down in less air being expelled. Prolonged chest breathing also tends to congest the front heart chakra, resulting in chest pain and difficulty in breathing.
Exercising has a cleansing effect—physically and etherically. Physically, waste matter and toxins are eliminated through sweating. When a person is exercising, the auras of the energy body pulsate; whitish gray light or used-up energy is expelled and fresh pranic energy is drawn in. The chakras, the meridians and the organs are cleansed of used-up energy and diseased energy. Blood and pranic circulations are greatly improved by regular exercise. The body feels better and lighter after exercising. Regular physical exercise is a must to maintain a clean, highly vitalized, healthy body.
Tai Chi, chi kung exercise, hatha yoga, dancing, martial arts, sports, jogging, hiking or brisk walking, if done regularly, have very good effects on the body. The left and right parts of the body should preferably be in balance, while exercising. Otherwise, the part of the body, which is not sufficiently exercised will become weaker and partially congested, which may manifest as pain or discomfort. Fifteen to thirty minutes of exercise daily is sufficient.
Intelligence requires the addition of love to become wisdom.
Lady Master Nada - Chohan of the Sixth Ray "Nada" means "nothing," which refers to her great humility.
Lady Nada - Sacral Chakra. Lady Nada, a beautiful ascended master written about in the first two "green books" of the St. Germain Press: Unveiled Mysteries, and The Magic Presence. She works on the ray of compassion and is on the Karmic Board, where she represents the third ray. Lady Nada works with mental healing and upliftment. The thousand petaled lotus on her forehead symbolizes enlightenment for the feminine, as well as the masculine, mental body. She teaches that intelligence requires the addition of love to become wisdom.
Art, perhaps you can ask Matt to change name of this board
to "Brokers Restricting Online Trading do to them being short"
they don't call em brokers for nuttin ya know.
OCSI - Oscient says Q3 revenue to be more than $11 million
Oct 11 (Reuters) - Biopharmaceutical firm Oscient Pharmaceuticals Corp. (OSCI.O: Quote, Profile, Research) said on Wednesday it expects total third-quarter revenues of slightly more than $11 million.
In a statement, the company said it expects the total cash, restricted cash and investments balance as of the quarter ended September 30 to be about $51 million. (Reporting by Swagata Gupta in Bangalore)
HYBT - Hybrid Technologies, Inc. 'OTCBB:HYBT' and GOOGLE 'NASDAQ:GOOG' Show the Power of Lithium to Zeitgeist Guests Colin Powell, Al Gore and the Nation's Top Business Leaders
Wednesday October 11, 7:30 am ET
Sergey Brin and Larry Page Bring World Leaders Together at the Conference
Hybrid Invited To Highlight Lithium NYC Taxi At Prestigious Google Zeitgeist Conference
NEW YORK, NEW YORK and PALO ALTO, CALIFORNIA--(MARKET WIRE)--Oct 11, 2006 -- Hybrid Technologies, Inc. (OTC BB:HYBT.OB - News), www.hybridtechnologies.com, emerging leaders in the development and marketing of lithium powered products worldwide, are proud to announce that Hybrid's latest lithium vehicles were selected by search engine powerhouse Google for presentation at the prestigious Zeitgeist Partner Forum.
For an enhanced press release, please click here: http://www.hybridtechnologies.com/media.php?mediaID=061011
Google co-founders Larry Page, president of Products, and Sergey Brin, president of Technology, bring together world leaders with innovative companies in an annual partner forum designed to challenge and solve world issues. This year's invitation-only conference featured CEO's from most major U.S. media corporations, as well as presentations from leaders in media, technology, entertainment, science, and philanthropy.
Sergey Brin and Larry Page, known for their environmental and innovative corporate management style, took Hybrid's lithium Smart Car and New York City's newest star, the all-lithium taxi, for a spin around the sprawling Google campus located in Mountain View, California.
The forum's featured speakers included former Vice President of the United States Al Gore, former Secretary of State Colin Powell, and Jordanian Queen Noor.
About Google Inc.: http://www.google.com/intl/en/about.html
About Hybrid Technologies: www.hybridtechnologies.com
Hybrid Technologies, Inc. (OTC BB:HYBT.OB - News) is an emerging leader in the development and marketing of lithium-powered products worldwide. Superior technology, coupled with aggressive marketing, positions Hybrid Technologies to lead the world into pollution-free, zero emissions living without consumers having to give up the comforts and performance to which they are accustomed.
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.
Contact:
Contacts:
Media Contact:
Hybrid Technologies, Inc.
1-888-HYBTECH (1-888-492-8324)
Email: pr@hybridtechnologies.com
Hybrid Technologies, Inc.
Investor Relations:
1-888-669-1808
(702) 926-9508 (FAX)
Email: info@hybridtechnologies.com
Website: http://www.hybridtechnologies.com
--------------------------------------------------------------------------------
Source: Hybrid Technologies, Inc.
SLJB - Acquires SAM Building Materials: $6M/Yr. Revenues From Regional Market Share Brought on Immediately
Tuesday October 10, 11:23 am ET
WINDSOR, ON--(MARKET WIRE)--Oct 10, 2006 -- Today the CEO of SLJB (Sulja Bros. Building Supplies, Ltd.) (Other OTC:SLJB.PK - News), Petar Vucicevich, announced the acquisition of SAM Building Materials Limited. The acquisition is of a regional "GSD" (Gypsum Supply Depot) situated in the Windsor/Ontario region with close proximity to markets in the US. The Company specializes in supplying Drywall and associated materials such as steel stud, wet board, acoustical ceilings, and associated finishing products in and around the Ontario/Michigan area. The company, at the time of acquisition, enjoyed a solid 10%+ of the Windsor area market share after only 6 years in business.
"We fully intend to advance the development of SAM beyond their already successful entry into a tough regional market," said SLJB CEO Petar Vucicevich. "SAM is a respected outfit here in the Windsor area, and as they adopt the SLJB moniker and available resources, we will serve to broaden their presence, along with all of SLJB and its affiliates."
An SLJB spokesperson concluded with a statement reiterating that the acquisition immediately places $6M in revenues to SLJB and that the ancillary benefits of increased purchasing volume and broader scope of expertise will only serve to enhance the bottom line of the value to SLJB shareholders. This acquisition was finalized on October 2, 2006.
Contact:
--------------------------------------------------------------------------------
Source: Sulja Bros. Building Supplies, Ltd.
Stock Futures Flat As Earnings Begin
Tuesday October 10, 7:20 am ET
Stock Futures Flat Ahead of 3Q Earnings Season; Overseas Markets Make Slight Advance
LONDON (AP) -- U.S. stock market futures were virtually unmoved Tuesday in the last trading session before third-quarter earnings season officially kicks off with results from Alcoa, the Dow industrials component.
Dow Jones futures were recently down 1 point, S&P 500 futures edged up 0.6 of a point and Nasdaq futures were up 2 points.
U.S. stocks ended higher Monday, with the Nasdaq Composite at its best level in five months, as a Fed official's soothing remarks on inflation, a going-private offer for Cablevision Systems and a $6 billion deal in the banking sector placed news of North Korea's nuclear test on the back burner. The Nasdaq Composite rose 0.5 percent, and 0.1 percent rises were seen for the Dow industrials and the S&P 500.
The economic schedule for Tuesday is light, with August wholesale inventories probably up 0.6 percent after a 0.8 percent rise last month.
Also, a speech from Dallas Federal Reserve President Richard Fisher could affect markets.
Traders will want to see if his views are similar to colleague Janet Yellen's, who said holding interest rates steady makes sense as policymakers come to grip with economic data, and ex-Fed chairman Alan Greenspan, who said that last week's rise in weekly mortgage applications could signal that the worst may well be over for the U.S. housing industry.
Crude-oil futures were little changed, with the November contract up 4 cents at $60 a barrel. Gold futures also held to a tight range.
The earnings calendar is also light, with Supervalu set to report results, ahead of the open on Tuesday.
After the market's close, Alcoa will release quarterly results, with the aluminum giant expected to earn 77 cents a share on revenue of $7.75 billion.
In Korea, LG.Philips LCD reported its second-straight quarterly loss as panel prices fell and inventory costs rose.
Elsewhere, Sovereign Bancorp is expected to force out Chairman and Chief Executive Jay Sidhu and name Vice Chairman Joseph P. Campanelli as president and CEO, The Wall Street Journal reported. An individual close to the situation told the paper that Sovereign would name a director, Michael Ehlerman, chairman. The changes are a compromise with Banco Santander, the Spanish bank that holds about a quarter of Sovereign, the Journal reported.
Two cruise operators were downgraded, with J.P. Morgan downgrading shares of both Carnival and Royal Caribbean Cruises to neutral. Though weakening oil prices and a mild hurricane season have lifted both company's shares since mid-August, there are headwinds ahead, the broker warned.
The same brokerage is taking a more positive stance on homebuilders, upgrading D.R. Horton Inc. and Standard Pacific Corp. to overweight from neutral and Toll Brothers Inc. to neutral from underweight.
International stock markets posted mild gains. The Nikkei 225 rose 0.25 percent after traders returned from a three-day holiday in Tokyo. The French CAC 40 rose 0.4 percent.
EGAN - eGain Strengthens Presence in Continental Europe
Tuesday October 10, 7:00 am ET
The New Talent Will Focus on Increasing Demand for Customer Service Solutions in Europe
AMSTERDAM, THE NETHERLANDS--(MARKET WIRE)--Oct 10, 2006 -- eGain Communications Corporation (OTC BB:EGAN.OB - News), a leading provider of customer service and contact centre software, announces today the appointment of four new team members to add to the eGain's sales team in Europe.
Marco Reinhoudt has joined eGain Communications in the position of Sales Manager responsible for the Dutch, German speaking markets. Marco has more than 18 years sales and management experience within the ICT sector.
Gina Spencer is responsible for managing and growing the Sales and Revenues in Belgium and the Scandinavian region. Gina has a wealth of Software Solution selling experience of more than twenty years.
Tanja Samsom is responsible for managing and growing channel within EMEA. Both direct and indirect sales experience in IT will help understanding and support the business needs of eGain partners
As Technical Account Manager Joris van Duppen will be supporting the Sales team in EMEA in pre-sales activities. With his multiple skills in consultancy and technical support across Europe, Joris will help expand and support the business needs of eGain.
"More businesses -- whether large or small -- are looking into faster and flexible solutions to increase the customer experience," said Lody Offenberg, Managing Partner at Tote-m business architects.
Offenberg continues: "We have worked successfully with eGain in the past and are pleased with eGain's initiative to expand their global presence by opening an office in the Netherlands. We are looking forward to working together on future opportunities with the local team in the region."
The new Sales team will be based in Amsterdam. They will focus on developing the business across Northern and Central Continental Europe
"The team is headed up by Ray Connolly who has been focusing on the European market for the last 5 years," said Andrew Mennie, General Manager EMEA for eGain. "Marco, Gina, Tanja and Joris will bring extensive international experience to eGain, and I am confident that they will bring tremendous focus and energy for their position and increase eGain's presence throughout the EMEA region."
eGain Europe currently maintains offices in Slough, UK (European Headquarters); Dublin, Ireland; Milan, Italy and Amsterdam, the Netherlands and has relationships with distributors throughout the entire region. The company's EMEA customers include: ABN Amro, Vodafone, HSBC, RDW, HMV and Orange.
About eGain
eGain (OTC BB:EGAN.OB - News) is a leading provider of customer service and contact centre software for in-house or on-demand deployment. Trusted by prominent enterprises and growing mid-sized companies worldwide, eGain has been helping organisations achieve and sustain customer service excellence for more than a decade. Twenty-four of the fifty largest global companies rely on eGain to transform their traditional call centres, help desks and Web customer service operations into multichannel customer interaction hubs. These hubs enable dramatically improved customer experience, unified multichannel customer service, end-to-end service process efficiencies, and enhanced contact centre performance.
eGain Service(TM) 7, the company's software suite, includes integrated, best-in-class applications for Web self-service, e-mail management, knowledge management, live Web collaboration through chat and co browsing, automation of fax and paper-based service interactions, case management and service fulfilment. These robust applications are built on the eGain Service Management Platform(TM) (eGain SMP(TM)), a scalable next-generation framework that includes end-to-end service process management, multichannel, multisite contact centre management and certified out-of-the-box integrations with leading call centre, content and business systems.
eGain OnDemand(TM), the industry's first-ever on-demand eService software, is a proven, robust and scalable solution that has been used by companies of all sizes to rapidly build customer interaction hubs for over eight years.
Headquartered in Mountain View, California, eGain has an operating presence in 18 countries and serves over 850 customers worldwide. To learn more about eGain, visit http://www.eGain.com or call the company's offices: London: +44 (0) 1753 464646; Dublin: +353 1 8472290; United States: +1 888 603 4246 ext. 9.
Contact:
eGain media contact
UK
Kerry Hallard/Nicola Craft
Buffalo Communications Ltd.
+44 (0) 207 292 8680
egain@buffalo.co.uk
UK or Benelux
Hilary de Rover
eGain Communications Ltd
+44(0) 1753 464689
hderover@egain.com
--------------------------------------------------------------------------------
Source: eGain
DSCO - Surfaxin Treated Premature Infants Require Fewer Re-Intubations Compared With Animal Derived Surfactants
Tuesday October 10, 7:00 am ET
WARRINGTON, Pa., Oct. 10, 2006 (PRIMEZONE) -- Discovery Laboratories, Inc. (NASDAQ:DSCO - News), today announced that additional clinical data from its SELECT and STAR Phase 3 clinical trials of Surfaxin(r) (lucinactant), for the prevention of Respiratory Distress Syndrome (RDS) in premature infants, were presented at the European Academy of Paediatrics Congress (Europaediatrics) in Barcelona, Spain. These data demonstrate that Surfaxin-treated infants require significantly less re-intubation and experience improved key clinical outcomes compared to those treated with the animal derived surfactants, Survanta(r) and Curosurf(r), the current market-leading products in the United States and Europe, respectively.
Recent data from Discovery's pivotal and supportive Phase 3 clinical trials, SELECT and STAR, demonstrate statistically significant reductions in re-intubation rates for Surfaxin-treated infants as follows:
-- In a pooling of both studies, re-intubation rates were significantly
lower for Surfaxin-treated infants compared with those treated with
the animal-derived surfactants (34.2% vs. 43.9%, respectively;
p = .005)
-- In the SELECT trial's comparison of Surfaxin with Survanta,
re-intubation rates were significantly lower for infants treated with
Surfaxin (34.6% vs. 42.8%, respectively; p = .014)
-- In the STAR trial's comparison of Surfaxin with Curosurf, re-intubation
rates were significantly lower for infants treated with Surfaxin (32.7%
vs. 47.2%, respectively; p = .048)
ADVERTISEMENT
Premature babies are often born with a lack of natural lung surfactant and are unable to absorb sufficient oxygen, resulting in RDS. These babies often require endotracheal intubation -- a breathing tube inserted in the infant's fragile airway -- allowing for surfactant administration and respiratory support via mechanical ventilation. This breathing tube is removed when the infant no longer requires ventilatory support. Unfortunately, many infants suffer a relapse in respiratory function that requires re-intubation. This repeated invasive intubation and prolonged mechanical ventilation increases the risk of airway damage, hospital stay, chronic lung disease (also known as bronchopulmonary dysplasia, BPD), and death. In addition, endotracheal intubation and prolonged mechanical ventilation dramatically increases the cost of treating these babies.
These data were presented at Europaediatrics by Fernando Moya, M.D., Chair of the SELECT study Steering Committee and Director of Neonatology at the Coastal Area Health Education Center, North Carolina. Dr. Moya commented, ``According to the Centers for Disease Control and Prevention, the most frequent cause of infant death in the United States is preterm birth. Premature infants often have lung dysfunction usually associated with RDS. Current surfactant treatment options for RDS are limited to animal derived surfactants harvested from bovine (cow) and porcine (pig) sources. Surfaxin has already shown a robust survival benefit compared to these animal derived surfactants. These new data are particularly important as they now show that Surfaxin decreases re-intubation procedures, which are associated with long-term respiratory morbidity, compared with animal derived alternatives. Any therapy capable of improving odds for survival while reducing complications associated with prematurity represents a potential significant advancement in neonatal care.''
Dr. Moya also presented previously reported long-term clinical data derived from a pooled analysis combining data from the SELECT and STAR trials in a symposium at Europaediatrics entitled ``Surfactant Therapy; Past, Present and Future.'' These data demonstrated that premature infants treated with Surfaxin experienced a significant survival benefit through one year of life compared with the currently available animal derived surfactants.
Surfaxin is a precision-engineered, peptide-containing, synthetic surfactant that is designed to closely mimic the function of natural human lung surfactant and represents a potential alternative to the animal-derived and non-protein containing synthetic surfactants. Surfactants are substances that are produced naturally in the lungs and are essential to the lungs' ability to absorb oxygen and maintain proper airflow through the respiratory system. Surfaxin, an investigational drug, is currently the subject of an Approvable Letter from the FDA for the prevention of RDS in premature infants.
RDS afflicts tens of thousands of premature infants in the United States each year, with a global at-risk population in excess of 500,000 infants. Approximately 75,000 infants are treated with surfactants in the United States annually.
About European Academy of Paediatrics Congress (Europaediatrics)
The European Academy of Paediatrics Congress (Europaediatrics) is the largest European congress of pediatrics and is a combination of two European pediatric subspecialty societies, ESPR/ESN (European Society for Paediatric Research / European Society of Neonatology) and the ESPNIC (European Society of Paediatric and Neonatal Intensive Care). This Congress provides top-level education and state-of-the-art information, particularly aimed for pediatric subspecialists and pediatricians involved in hospital based pediatrics.
About Discovery Labs
Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Replacement Therapies (SRT) for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery's technology produces a precision-engineered surfactant that is designed to closely mimic the essential properties of natural human lung surfactant. Discovery believes that its proprietary SRT pipeline has the potential to advance respiratory medicine and address a variety of respiratory diseases affecting premature infants, children and adults.
Discovery's lead product candidate, Surfaxin, is the subject of an Approvable Letter from the FDA for the prevention of Respiratory Distress Syndrome in premature infants. Surfaxin(r) is also being developed for the prevention and treatment of Bronchopulmonary Dysplasia in premature infants. Aerosurf(tm), Discovery's aerosolized SRT, is being developed initially to treat premature infants suffering from respiratory disorders and is intended to obviate the need for intubation and conventional mechanical ventilation. Discovery's SRT pipeline also includes programs addressing Acute Lung Injury, Acute Respiratory Failure, Cystic Fibrosis, Acute Respiratory Distress Syndrome, and other respiratory conditions. For more information, please visit our corporate website at http://www.Discoverylabs.com.
To the extent that statements in this press release are not strictly historical, including statements as to business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of Discovery's product development, events conditioned on stockholder or other approval, or otherwise as to future events, all such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Among the factors which could affect Discovery's actual results and could cause results to differ from those contained in these forward-looking statements are the risk that financial conditions may change, risks relating to the progress of Discovery's research and development, the risk that Discovery will not be able to raise additional capital or enter into additional collaboration agreements (including strategic alliances for aerosol and Surfactant Replacement Therapies), the risk that Discovery will not be able to develop or otherwise provide for a successful sales and marketing organization in a timely manner, if at all, the risk that approval by the FDA or other health regulatory authorities of any applications filed by Discovery may be withheld, delayed and/or limited by indications or other label limitations, the risk that any such regulatory authority will not approve the marketing and sale of a drug product even after acceptance of an application filed by Discovery for any such drug product, risks that the Chemistry, Manufacturing and Controls (CMC) section of Discovery's New Drug Application will not satisfy the FDA, risk in the FDA or other regulatory agency review process generally, risks relating to the ability of Discovery or Discovery's third party contract manufacturers and development partners to manufacture or provide Discovery with adequate supplies of drug substance, drug products and expertise for completion of any of Discovery's clinical studies, risks relating to drug manufacturing by Discovery, risks relating to the integration of manufacturing operations into Discovery's existing operations, other risks relating to the lack of adequate supplies of drug substance and drug product for completion of any of Discovery's clinical studies, risks relating to the ability of Discovery and its collaborators to develop, manufacture and successfully commercialize products that combine Discovery's drug products with innovative aerosolization technologies, risks relating to the significant, time-consuming and costly research, development, pre-clinical studies, clinical testing and regulatory approval for any products that we may develop independently or in connection with Discovery's collaboration arrangements, and risks relating to the development of competing therapies and/or technologies by other companies. Companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced clinical trials, even after obtaining promising earlier trial results. Data obtained from tests are susceptible to varying interpretations, which may delay, limit or prevent regulatory approval. Those associated risks and others are further described in Discovery's filings with the Securities and Exchange Commission including the most recent reports on Forms 10-K, 10-Q and 8-K, and any amendments thereto.
Contact:
Discovery Laboratories
Investor Relations
Lisa Caperelli
(215) 488-9413
--------------------------------------------------------------------------------
Source: Discovery Laboratories
ONGO - On The Go to Ship $200,000 Hardware Order to Major Business Process Outsourcing Company
Monday October 9, 4:00 pm ET
CONCORD, Ontario, Oct. 9 /PRNewswire-FirstCall/ -- On The Go Technologies Group (OTC Bulletin Board: ONGO - News), a leading multi-industry computer hardware, software and systems integrator, announced today a large systems order from one of North America's largest business process outsourcing companies. Valued at $200,000 and set to ship this week, the order consists of a complete IBM Blade Center and accessories.
OTG is working together with some of North America's leading hardware and software suppliers and payment solutions providers to provide this client with essential equipment for their network infrastructure. This includes Xerox, Telus, BancTec, Carreker and global financial electronic commerce services and products provider CheckFree Corporation.
As an industry leader and one of North America's premier outsourcing companies for financial and accounting-related business processes, the client provides services designed to transform and streamline its customers' businesses in terms of physical and electronic check and payment processing, statement production and document management.
OTG President and CEO Stuart Turk said, "The orders received in this first fiscal quarter of 2007 have been consistently higher than those of previous quarters. We look forward to growing alongside this client, providing them with the brand named quality and innovative service performance necessary for the company to maintain its edge in the North American market."
About On The Go Technologies Group
On The Go Technologies Group is a North American corporation focused on acquiring versatile and profitable companies in the IT sector. OTG has established itself as a respected industry competitor through its four divisions: OTG Enterprise, catering to Fortune 1000 and SME clientele and vendors such as HP, Apple, IBM, SGI, Extreme Networks and Adobe; OTG Creative, a prominent systems integrator in the U.S. and Canadian digital entertainment industry; and OTC Healthcare and OTG Research compiling sophisticated digital solutions and networks for the diagnostic medical community and scientific research communities respectively. The company's intention is to maintain sustained growth in the years to come via continued development in its existing divisions and an aggressive acquisition schedule. For more information, visit http://www.oghc.com or http://www.onthegohealthcare.com/video.
To view a company profile, visit
http://www.hawkassociates.com/ongoprofile.aspx.
To be added to On The Go Technologies Group's e-mail list for company news, visit http://www.onthegohealthcare.com/new_site/inv_pkg_form.htm and http://hawkassociates.com/email.aspx. For investor relations information, contact Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info@hawkassociates.com or visit http://www.hawkassociates.com and http://www.americanmicrocaps.com.
This press release contains forward-looking statements that involve a number of risks and uncertainties. These forward-looking statements contain words such as "expects," "believes," "anticipates" and "intends." Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to, economic conditions affecting the B2B environment; continued ability to obtain hardware, software and peripherals at competitive costs; the company's ability to finance its planned expansion efforts; the company's ability to manage its planned growth; changes in regulations affecting the company's business; and such other risks disclosed from time to time in the company's reports filed with the Securities and Exchange Commission. The company does not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in management's expectations, except as required by law.
--------------------------------------------------------------------------------
Source: On The Go Technologies Group
GDVI - Global Diversified Industries, Inc. Announces Winning Key Piggyback Rights, Making it Easier to Sell New Products to California School Districts
Monday October 9, 5:49 pm ET
CHOWCHILLA, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Global Diversified Industries, Inc. (OTC Bulletin Board: GDVI - News), focused on the modular building industry with emphasis on the education market (http://www.gdvi.net) , today announced that in a public bidding process it won a contract with a Southern California School District which has "piggyback rights" that allows Global Diversified to sell its new Aurora product line to school districts throughout California in a much simpler manner, at a fixed price, that avoids lengthy public bidding.
"This is absolutely crucial for the continued growth of our Company. We are delighted with this success and believe it will result in significant new business for Global Diversified Industries," said Phil Hamilton, CEO.
"Our Aurora products are very popular for California school districts, and, combined with these new piggyback rights, we believe we are headed in the right direction for success for the Company and its shareholders," Global Diversified Industries CEO said.
About Global Diversified Industries, Inc.
Global Diversified Industries, Inc. is a holding company whose subsidiary Global Modular, Inc. is engaged in the modular construction marketplace with an emphasis on educational projects. It incorporates the latest in construction software, allowing it to better manage projects incorporating cost vs. profit ratios, construction and manufacturing schedules, purchasing, receiving and other facets of industrial management. The Company's work is found in Northern and Southern California, with numerous projects planned for school systems throughout the state.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release. For investor information contact:
Paul Knopick
949-707-5365
pknopick@eandecommunications.com
--------------------------------------------------------------------------------
Source: Global Diversified Industries, Inc.
GDVI - Global Diversified Industries, Inc. Announces Winning Key Piggyback Rights, Making it Easier to Sell New Products to California School Districts
Monday October 9, 5:49 pm ET
CHOWCHILLA, Calif., Oct. 9 /PRNewswire-FirstCall/ -- Global Diversified Industries, Inc. (OTC Bulletin Board: GDVI - News), focused on the modular building industry with emphasis on the education market (http://www.gdvi.net) , today announced that in a public bidding process it won a contract with a Southern California School District which has "piggyback rights" that allows Global Diversified to sell its new Aurora product line to school districts throughout California in a much simpler manner, at a fixed price, that avoids lengthy public bidding.
"This is absolutely crucial for the continued growth of our Company. We are delighted with this success and believe it will result in significant new business for Global Diversified Industries," said Phil Hamilton, CEO.
"Our Aurora products are very popular for California school districts, and, combined with these new piggyback rights, we believe we are headed in the right direction for success for the Company and its shareholders," Global Diversified Industries CEO said.
About Global Diversified Industries, Inc.
Global Diversified Industries, Inc. is a holding company whose subsidiary Global Modular, Inc. is engaged in the modular construction marketplace with an emphasis on educational projects. It incorporates the latest in construction software, allowing it to better manage projects incorporating cost vs. profit ratios, construction and manufacturing schedules, purchasing, receiving and other facets of industrial management. The Company's work is found in Northern and Southern California, with numerous projects planned for school systems throughout the state.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release. For investor information contact:
Paul Knopick
949-707-5365
pknopick@eandecommunications.com
--------------------------------------------------------------------------------
Source: Global Diversified Industries, Inc.
9/10/2006 - NVAS to THPW
from NVAS to THPW - Thorium Power, Ltd. (formerly Novastar Resources Ltd.), a Nuclear Energy Technology Company, Announces Symbol Change
Monday October 9, 6:20 pm ET
MCLEAN, Va., Oct. 9 /PRNewswire-FirstCall/ -- In connection with the recent acquisition of Thorium Power, Inc. by Thorium Power, Ltd. (formerly Novastar Resources Ltd. - OTC Bulletin Board: NVAS), on October 6th, 2006 the name of the company changed from Novastar Resources Ltd. to Thorium Power, Ltd. To reflect the name change, the company's trading symbol will change from "NVAS (OTC Bulletin Board)" to "THPW (OTC Bulletin Board)" effective at the open of business on October 10th, 2006.
About Thorium Power Ltd.:
Thorium Power Ltd. is involved in the nuclear power sector. Its focus is on technologies and services that will benefit from, and help lead to, expanded use of nuclear power generation. The company has assembled an International Advisory Board comprised of key national and international leaders in the fields of Nuclear Energy, Finance, Government Affairs, Non-proliferation and Diplomacy. Thorium Power Ltd. also has put together a Technical Advisory Board made up of top scientists and practitioners from the world's major nuclear companies.
About Thorium Power Inc.:
Thorium Power Inc. is a leading developer of proliferation resistant nuclear fuel technologies. Thorium Power Inc. designs nuclear fuels, obtains patent protection on these fuels, and coordinates fuel development with large entities and governments. The company has been working in Russia with Russian nuclear engineers and scientists for over a decade. Thorium Power Inc. is a wholly owned subsidiary of Thorium Power Ltd.
DISCLAIMER
This press release may include certain statements that are not descriptions of historical facts, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements may include the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, statements regarding benefits of the proposed merger and other forward-looking terminology such as "may," "expects," "believes," "anticipates," "intends," "plans," "projects" or similar terms, variations of such terms or the negative of such terms. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements made herein. These risks are discussed in the reports that we file with the Securities and Exchange Commission, including our latest annual report on Form 10-KSB. Such information is based upon various assumptions made by, and expectations of, our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to significant economic and competitive uncertainties and contingencies beyond our control and upon assumptions with respect to the future business decisions which are subject to change. Accordingly, there can be no assurance that actual results will meet expectations and actual results may vary (perhaps materially) from certain of the results anticipated herein.
Further information is available on Thorium Power Ltd.'s websites at http://www.novastarresources.com and http://www.thoriumpower.com
For more information:
Peter Charles
Thorium Power Ltd.
Ph: (703) 918-4932
Email: ir@thoriumpower.com
--------------------------------------------------------------------------------
Source: Thorium Power, Ltd.
AMZB - Amazon Biotech, Inc. Announces Development of Next-Generation Anti-Viral AIDS Drug Formula
Monday October 9, 6:00 pm ET
Active Ingredients Exhibit -- Immune Modulator Functions and Anti-Viral Properties
NEW YORK, NY--(MARKET WIRE)--Oct 9, 2006 -- Amazon Biotech, Inc. (OTC BB:AMZB.OB - News) (Frankfurt:B2D.F - News) today announced that it has developed a next-generation AIDS formulation which includes both immune modulator functions and anti-viral activity. This formulation, based on Amazon's Phase I/II developmental drug AMZ0026, includes additional active ingredients found in a plant which are known in the literature to posses anti-viral properties.
The entire formulation is comprised of whole plant pharmaceuticals, in line with Amazon Biotech's treatment philosophy. Amazon is now pursuing relevant intellectual property protection and IND (Investigational New Drug application) status from the FDA for this novel formulation. Dr. Mechael Kanovsky, President of Amazon Biotech, said, "We are excited to have reached this stage of development with this promising therapeutic agent."
About Amazon Biotech, Inc.
Amazon Biotech, Inc. is a natural plant pharmaceutical company, primarily developing immune modulator drugs. AMZ0026 is the company's first such drug, which is to be used for the treatment of HIV/AIDS. The company plans on initiating Phase I/II clinical studies of AMZ0026 in the near future, with an eventual goal of attracting a joint venture partner with a major pharmaceutical company in Phase III trials, or follow the FDA Fast Track program to market. Amazon Biotech specializes in natural plant pharmaceutical drugs and is focused on bringing healthier pharmaceutical drugs to market.
Additional information on Amazon Biotech may be found at: http://www.amazonbiotech.com.
Forward-Looking Statements
"Safe-Harbor" Statement Under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, including statements regarding any potential sales of products as well as statements that include the words "believes," "expects," "anticipates," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Amazon Biotech, to differ materially from those implied or expressed by such forward-looking statements. Such factors include, among others, the risk factors included in Amazon Biotech's subsequent reports filed with the Securities and Exchange Commission under the Exchange Act. This press release speaks as of the date first set forth above and Amazon Biotech assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contact:
Contact:
LC Group
Rick Lutz
(404) 261-1196
--------------------------------------------------------------------------------
Source: Amazon Biotech, Inc.
AMZB - Amazon Biotech, Inc. Announces Development of Next-Generation Anti-Viral AIDS Drug Formula
Monday October 9, 6:00 pm ET
Active Ingredients Exhibit -- Immune Modulator Functions and Anti-Viral Properties
NEW YORK, NY--(MARKET WIRE)--Oct 9, 2006 -- Amazon Biotech, Inc. (OTC BB:AMZB.OB - News) (Frankfurt:B2D.F - News) today announced that it has developed a next-generation AIDS formulation which includes both immune modulator functions and anti-viral activity. This formulation, based on Amazon's Phase I/II developmental drug AMZ0026, includes additional active ingredients found in a plant which are known in the literature to posses anti-viral properties.
The entire formulation is comprised of whole plant pharmaceuticals, in line with Amazon Biotech's treatment philosophy. Amazon is now pursuing relevant intellectual property protection and IND (Investigational New Drug application) status from the FDA for this novel formulation. Dr. Mechael Kanovsky, President of Amazon Biotech, said, "We are excited to have reached this stage of development with this promising therapeutic agent."
About Amazon Biotech, Inc.
Amazon Biotech, Inc. is a natural plant pharmaceutical company, primarily developing immune modulator drugs. AMZ0026 is the company's first such drug, which is to be used for the treatment of HIV/AIDS. The company plans on initiating Phase I/II clinical studies of AMZ0026 in the near future, with an eventual goal of attracting a joint venture partner with a major pharmaceutical company in Phase III trials, or follow the FDA Fast Track program to market. Amazon Biotech specializes in natural plant pharmaceutical drugs and is focused on bringing healthier pharmaceutical drugs to market.
Additional information on Amazon Biotech may be found at: http://www.amazonbiotech.com.
Forward-Looking Statements
"Safe-Harbor" Statement Under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, including statements regarding any potential sales of products as well as statements that include the words "believes," "expects," "anticipates," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Amazon Biotech, to differ materially from those implied or expressed by such forward-looking statements. Such factors include, among others, the risk factors included in Amazon Biotech's subsequent reports filed with the Securities and Exchange Commission under the Exchange Act. This press release speaks as of the date first set forth above and Amazon Biotech assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contact:
Contact:
LC Group
Rick Lutz
(404) 261-1196
--------------------------------------------------------------------------------
Source: Amazon Biotech, Inc.
CPHI - China Pharma Holdings, Inc. Receives Approval for Granisetron Hydrochloride Injection
Monday October 9, 11:41 am ET
HAIKOU CITY, China, Oct. 9 /Xinhua-PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI.OB - News) today announced it had received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market its Granisetron Hydrochloride Injection product.
Granisetron hydrochloride is indicated for the prevention of nausea and vomiting associated with radiation treatment and chemotherapy in cancer patients. It is a highly selective receptor antagonist against 5-hydroxytryptamine 3(5-HT3), which is produced during chemotherapy and radiation treatment that triggers emetic reactions in these patients. Granisetron hydrochloride is a prescription drug and is administered within 30 minutes before initiation of chemotherapy treatment. China Pharma intends to market this product exclusively within the greater China area. Currently, the sales statistics for granisetron products in China are not available; however, the market for injectable granisetron hydrochloride is valued over $1 billion in the U.S. and Canada.
"This new approval underlines the breadth of our product portfolio and pipeline development," commented Zhi-lin Li, President and CEO. "It adds a new dimension to our current extensive product line that treats a wide range of diseases and conditions in the Chinese population, including cardiovascular, CNS and infectious diseases. This product supports our strategy of growth through product development."
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, vascular diseases, CNS and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty bio-pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand, increased competition, failure to obtain or maintain intellectual property protection, downturns in the Chinese economy, uncompetitive levels of research and development, failure to obtain regulatory approvals, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission.
--------------------------------------------------------------------------------
Source: China Pharma Holdings, Inc.
woohoo, flipped for half penny this morn..out now and wanted more but not trusting much now.
SEIH - S3 Investment Company Issues Newsletter Reviewing Recent Events and Upcoming Annual Report
Monday October 9, 10:28 am ET
TEMECULA, CA--(MARKET WIRE)--Oct 9, 2006 -- S3 Investment Company, Inc. (OTC BB:SEIH.OB - News), a holding company with two subsidiaries doing business in the China market, today issued an investor newsletter highlighting the company's expectations for its upcoming annual report and reviewing important events of the last two months.
A PDF version of the September/October 2006 newsletter can be viewed on the company's website at www.s3investments.com/newsletter.asp.
"We continue in our commitment to communicate with our shareholders as we await the filing of S3's 10-KSB Annual Report," stated Jim Bickel, chief executive officer of S3 Investment Company. "The annual report is expected to include some very strong financial results for SINO UJE and Redwood Capital, but even more importantly, our subsidiaries are now very well positioned for significant long-term growth. Armed with the information in our upcoming annual report and other indications of future expansion, we believe we have the tools to develop S3 into a company that builds tangible value and return for shareholders."
The September/October newsletter includes articles on the expansion of operations for S3 subsidiaries SINO UJE, Ltd. and Redwood Capital, Inc., a report on SINO UJE revenues for the month of August, the appointment of a manager of the "For Life" product line in China, and details on Redwood Capital's participation in an economic/trade event in China.
"These are all important recent events related to the operations of our subsidiaries in China, and we are extremely confident that S3 is now on the verge of even greater future development and much broader recognition in the U.S. public markets," added Mr. Bickel.
To sign up to receive information by email directly from S3 Investment Company when new press releases, investor newsletters, SEC filings or other information is disclosed, please visit http://www.s3investments.com/ealert.asp.
About S3 Investment Company
S3 Investment Company, Inc. (http://www.s3investments.com) is a holding company with two subsidiaries doing business in the China market. S3 holds a 100% equity interest in Redwood Capital (http://www.redwoodcapinc.com), which assists private Chinese companies in accessing U.S. capital markets by utilizing a network of investment banking relationships, and a 51% equity interest in SINO UJE (http://www.sinouje.com), a non-stocking distributor of medical and industrial high-tech products to markets throughout China. SINO UJE has been granted exclusive distribution rights in China to medical and industrial products manufactured by leading companies in Europe, North America and Japan. These products are marketed to end-users, including major Chinese hospitals and private companies in a variety of fields, as well as original equipment manufacturers (OEMs), such as Phillips, Siemens and GE, that package the products with their technologies.
Any statements contained herein related to future events are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on forward-looking statements. S3 Investment Company, Inc. undertakes no obligation to update any such statements to reflect actual events.
Contact:
Contact:
Gemini Financial Communications
A. Beyer
(951) 587-8072
Email Contact
Equiti-trend Advisors LLC
Investor Communication Representatives
Toll-Free (800) 585-6988
--------------------------------------------------------------------------------
Source: S3 Investment Company
lol, bet you would, no worries, next week it will move.
At the very least, to the nearest incoming comet.